{"url_path":"/sec/wgrx/8-k/2026-06-03/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"8-K/A","doc_date":"2026-06-03","source_url":"https://www.sec.gov/Archives/edgar/data/2030763/0001493152-26-027063-index.html","accession_number":"0001493152-26-027063","cik":"0002030763","ticker":"WGRX","issuer_name":"Wellgistics Health, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/2030763/0001493152-26-027063-index.html","primary_entity_key":"0002030763","primary_entity_name":"Wellgistics Health, Inc."},"word_count":389,"has_tables":true,"body_markdown":"true\n0002030763\n\n0002030763\n\n2026-05-27\n2026-05-27\n\niso4217:USD\n\nxbrli:shares\n\niso4217:USD\n\nxbrli:shares\n\n \n\n \n\n \n\n**UNITED\nSTATES**\n\n**SECURITIES\nAND EXCHANGE COMMISSION**\n\n**Washington,\nD.C. 20549**\n\n \n\n**FORM\n8-K/A**\n\n**Amendment\nNo. 2**\n\n \n\n**CURRENT\nREPORT**\n\nPursuant\nto Section 13 or 15(d) of the Securities Exchange Act of 1934\n\n \n\nDate\nof Report (Date of earliest event reported): May 27, 2026\n\n \n\n**WELLGISTICS\nHEALTH, INC.**\n\n(Exact\nname of registrant as specified in its charter)\n\n \n\n**Delaware**\n \n**001-42530**\n \n**93-3264234**\n\n(State\nor other jurisdiction\n\nof\nincorporation)\n\n \n\n(Commission\n\nFile\nNumber)\n\n \n\n(IRS\nEmployer\n\nIdentification\nNo.)\n\n \n\n**3000\nBayport Drive**\n\n**Suite\n950**\n\n**Tampa,\nFL**\n\n \n**33607**\n\n(Address\nof principal executive offices)\n \n(Zip\nCode)\n\n \n\nRegistrant’s\ntelephone number, including area code: (844) 203-6092\n\n \n\n**Not\nApplicable**\n\n(Former\nname or former address, if changed since last report)\n\n \n\n☐\nWritten\ncommunications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)\n\n \n \n\n☐\nSoliciting\nmaterial pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)\n\n \n \n\n☐\nPre-commencement\ncommunications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))\n\n \n \n\n☐\nPre-commencement\ncommunications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))\n\n \n\nSecurities\nregistered pursuant to Section 12(b) of the Act:\n\n \n\n**Title\nof each class**\n \n**Trading\nSymbol(s)**\n \n**Name\nof each exchange on which registered**\n\nCommon\nStock, $0.0001 par value per share\n \nWGRX\n \nThe\nNasdaq Capital Market LLC\n\n \n\nIndicate\nby check mark whether the registrant is an emerging growth company as defined in Rule 405 under the Securities Act of 1933 or Rule 12b-2\nunder the Securities Exchange Act of 1934.\n\n \n\nEmerging\ngrowth company ☒\n\n \n\nIf\nan emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying\nwith any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐\n\n \n\n \n\n \n\n \n\n \n\n \n\n**Explanatory\nNote**\n\n** **\n\nThis\nAmendment No. 2 to the Current Report on Form 8-K (the “Amendment No. 2”) further amends the Current Report on Form 8-K filed\nby Wellgistics Health, Inc. (the “Company”) on May 29, 2026, as amended by Amendment No. 1 filed on June 2, 2026. The purpose\nof this Amendment No. 2 is to replace and refile Exhibit 4.3 included with Amendment No. 1. Other than as described above, this Amendment\nNo. 2 does not modify or update any disclosures in or exhibits to the Original Report or Amendment No. 1, nor does it reflect any events\nthat may have occurred subsequent to the Original Report."}